Holocene Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Holocene Advisors’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-201,912	Closed	-$10.7M	–	878
2020 Q3	$10.7M	Buy	201,912 +93,960	+87%	+$5.59M	0.08%	225
2020 Q2	$6.29M	Sell	107,952 -52,915	-33%	-$2.84M	0.06%	202
2020 Q1	$6.34M	Buy	+160,867	New	+$9.41M	0.07%	170
2019 Q4	–	Sell	-282,427	Closed	-$15M	–	799
2019 Q3	$15M	Buy	282,427 +151,287	+115%	+$7.76M	0.15%	123
2019 Q2	$6.7M	Buy	131,140 +21,746	+20%	+$1.01M	0.09%	148
2019 Q1	$5.66M	Buy	+109,394	New	+$5.3M	0.09%	126
2018 Q2	–	Sell	-6,718	Closed	-$238K	–	761
2018 Q1	$238K	Buy	+6,718	New	+$263K	0.01%	475

Other funds holding SYNH

Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

THLTP

Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Holocene Advisors's SYNH Position: Q4 2020 in Review

Holocene Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2020, closing a stake of 201,912 shares — an estimated $10.7M sold.

Holocene Advisors first reported a position in SYNH in Q1 2018 and held it in 7 quarters. The position peaked at $15M in Q3 2019. 313 funds tracked by Wall St. Rank hold SYNH as of Q4 2020.

Holocene Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2020 after selling out during the quarter.
Holocene Advisors sold 201,912 Syneos Health, Inc. Class A Common Stock shares in Q4 2020, an estimated $10.7M.
Holocene Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2018 and held it in 7 quarters.
Holocene Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $15M in Q3 2019.
313 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2020.

Based on Holocene Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.